Recurrence preventive effect of a single immediate postoperative prophylactic intravesical instillation with Pirarubicin for non-muscle invasive bladder cancer
Phase 2
Recruiting
- Conditions
- on-muscle invasive bladder cancer
- Registration Number
- JPRN-UMIN000011441
- Lead Sponsor
- Osaka University Graduate School of Medicine,Department of Organ Specific Regulation (Urology)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Not undergoing TURBT (2) Target at 2ndTUR or BCG therapy (3) Patients with historically or presently disease of upper urinary tract urothelial cell carcinoma. (4) Presence of risk perforans bladder or rebleeding by wide TURBT (5) Presence of active other cancers. (6) Funcion of all organs are without severe dysfunction. (7) Lymph node metastasis or ogan metastasis (8) After TURBT,patients didn`t undergo intravesical therapy with pirarubicin. (9) Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The period from a 1st TURBT to the 1st recurrence (Duration of primary recurrence-free survival)
- Secondary Outcome Measures
Name Time Method The period from a 1st TURBT to the 2nd recurrence The period from a 2nd TURBT to the 2nd recurrence Safety